卡尔-T细胞点燃抗瘤免疫力
Darya Alizadeh1, Christine E Brown1
1Department of Hematology and Hematopoietic Cell Transplantation (T Cell Therapeutics Research Laboratories), City of Hope, Beckman Research Institute and Medical Center, Duarte, CA 91010, USA.
Trends in immunology
|August 31, 2023
概括
在小鼠中用疫苗增强仿真抗原受体 (CAR) -T细胞治疗促进免疫反应和抗原传播. 这种方法有助于消除各种固体瘤,这是癌症免疫治疗的关键目标.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 通过抗原扩散扩大免疫反应是癌症免疫疗法的关键挑战.
- 化学抗原受体 (CAR) -T细胞疗法已经显示出希望,但面临着抗原异质瘤的挑战.
研究的目的:
- 调查疫苗增强CAR-T细胞是否可以增强内源免疫力并促进抗原传播.
- 确定增强的CAR-T细胞消除抗原多样化的固体瘤的机制.
主要方法:
- 化学抗原受体 (CAR) - - T 细胞被给予具有固体瘤的小鼠.
- 疫苗增强剂被用来增强免疫反应.
- 分析了干扰素- (IFNγ) 水平和抗原传播.
主要成果:
- 疫苗刺激小鼠的CAR-T细胞显著促进了内源性免疫反应.
- 这种方法导致了抗原的扩散,使抗原异质的固体瘤能够被消除.
- 瘤消除的机制严重依赖于干扰素- (IFNγ).
结论:
- 疫苗增强CAR-T细胞是一种可行的策略,可以在癌症治疗中扩大免疫反应.
- 通过IFNγ介导的抗原扩散对于使用这种方法消除各种固体瘤至关重要.
- 这项研究为改善CAR-T细胞治疗对复杂癌症的疗效提供了一个有希望的机制.
相关概念视频
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Cytotoxic T Cells-mediated Immune Response
963
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
963
T Cell Activation and Clonal Selection
804
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
804
Antigens Involved in Adaptive Immunity
538
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
538
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Cell-mediated Immune Responses
68.8K
Overview
68.8K


